Stay updated on DARIA Trial: Daratumumab + Ixazomib in Multiple Myeloma
Sign up to get notified when there's something new on the DARIA Trial: Daratumumab + Ixazomib in Multiple Myeloma page.

Latest updates to the DARIA Trial: Daratumumab + Ixazomib in Multiple Myeloma page
- Check6 days agoChange DetectedThe page now lists 'Multiple myeloma' and a related topics section including MedlinePlus Genetics, and the site's revision tag is updated from v3.6.2 to v3.6.3.SummaryDifference0.2%

- Check13 days agoChange DetectedRevision: v3.6.2 was added. The page's related topics section was pruned to remove 'Multiple myeloma', 'related topics:', 'MedlinePlus Genetics', and the older 'Revision: v3.6.0', leaving the update focused on versioning rather than study content.SummaryDifference0.2%

- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedAdded navigation and help sections such as 'Last verified', 'Last known status was', 'How to Read a Study Record', 'Common Questions', and 'How to Join a Study', plus related topic links (Intervention/Treatment, Multiple myeloma, MedlinePlus Genetics) and updated the revision tag to v3.6.0. Removed older labels including 'Verified', 'Last known status was:', 'Intervention / Treatment', and 'Revision: v3.5.5'.SummaryDifference2%

- Check34 days agoChange DetectedThe page footer revision tag was updated from v3.5.4 to v3.5.5, indicating a maintenance version of the record.SummaryDifference0.1%

- Check41 days agoChange DetectedThe page’s disease label and a related topics section linking to MedlinePlus Genetics were removed, reducing visibility of the condition being studied and access to related resources.SummaryDifference0.2%

- Check55 days agoChange DetectedA new revision label v3.5.4 was added and the previous label v3.5.3 was removed. This update reflects an adjustment to the page's version information.SummaryDifference0.1%

Stay in the know with updates to DARIA Trial: Daratumumab + Ixazomib in Multiple Myeloma
Enter your email address, and we'll notify you when there's something new on the DARIA Trial: Daratumumab + Ixazomib in Multiple Myeloma page.